These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2667873)

  • 41. [Histomorphometry. Method for evaluating the bone mass].
    Meunier PJ; Chavassieux P
    Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):669-73. PubMed ID: 4095470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis.
    Legrand E; Chappard D; Pascaretti C; Duquenne M; Krebs S; Rohmer V; Basle MF; Audran M
    J Bone Miner Res; 2000 Jan; 15(1):13-9. PubMed ID: 10646109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone microarchitecture in osteoporotic men: universal or corticosteroid dependent?
    Hordon LD; Aaron JE
    J Bone Miner Res; 2001 Jul; 16(7):1374-5. PubMed ID: 11450715
    [No Abstract]   [Full Text] [Related]  

  • 44. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
    Ikeda S; Akahoshi S; Sakai A; Nakamura T
    Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome.
    Meunier PJ; Dempster DW; Edouard C; Chapuy MC; Arlot M; Charhon S
    Adv Exp Med Biol; 1984; 171():191-200. PubMed ID: 6720458
    [No Abstract]   [Full Text] [Related]  

  • 46. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroid-induced osteoporosis.
    Bockman RS; Weinerman SA
    Orthop Clin North Am; 1990 Jan; 21(1):97-107. PubMed ID: 2404239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
    Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
    Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mechanisms of bone loss in osteoporosis].
    Chavassieux P; Meunier PJ
    Rev Prat; 1995 May; 45(9):1083-8. PubMed ID: 7792529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study.
    Recker RR; Ste-Marie LG; Langdahl B; Masanauskaite D; Ethgen D; Delmas PD
    J Clin Densitom; 2009; 12(1):71-6. PubMed ID: 19084450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary osteoporosis.
    Reid DM; Harvie J
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):83-99. PubMed ID: 9222487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of osteoporosis: treatment of estradiol deficiency.
    Ettinger B
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):12S-17S. PubMed ID: 3173936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversity of bone cell activity as a histomorphometric feature of idiopathic osteoporosis in men.
    Galic E; Krpan D; Mirat J; Kusec V
    Aging Male; 2010 Mar; 13(1):18-24. PubMed ID: 20148745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural mechanisms of trabecular bone loss in primary osteoporosis: specific disease mechanism or early ageing?
    Croucher PI; Garrahan NJ; Compston JE
    Bone Miner; 1994 May; 25(2):111-21. PubMed ID: 8086850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
    Bradbeer JN; Arlot ME; Meunier PJ; Reeve J
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):282-9. PubMed ID: 1424211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Trabecular Bone Score (TBS) Complements DXA and the FRAX as a Fracture Risk Assessment Tool in Routine Clinical Practice.
    Hans D; Šteňová E; Lamy O
    Curr Osteoporos Rep; 2017 Dec; 15(6):521-531. PubMed ID: 28988401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods and application of bone densitometry in clinical diagnosis.
    Wahner HW; Riggs BL
    Crit Rev Clin Lab Sci; 1986; 24(3):217-33. PubMed ID: 3539521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.